How should a low-lying placenta be managed during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Low-Lying Placenta During Pregnancy

Women with a low-lying placenta identified at the mid-pregnancy anomaly scan should undergo follow-up transvaginal ultrasound at 32 weeks, with an additional scan at 36 weeks if the placenta remains low-lying, to determine the safest mode of delivery. 1

Diagnostic Definitions and Initial Screening

The mid-pregnancy routine fetal anomaly scan (18+6 to 21+6 weeks) should include placental localization to identify women at risk 1. Use these specific definitions:

  • Low-lying placenta: Placental edge <20 mm from the internal os (for pregnancies >16 weeks)
  • Placenta previa: Placenta directly covering the internal os 1

Transvaginal ultrasound (TVS) is superior to transabdominal scanning and is safe for diagnosing placental position, particularly for posterior placentas 1. If the placental edge is ≥20 mm from the internal os on TVS, manage as routine pregnancy with no increased cesarean risk 1.

Follow-Up Imaging Protocol

If low-lying placenta or previa is identified at the anomaly scan:

  1. 32-week TVS is mandatory to assess for persistence 1

    • 90% of low-lying placentas resolve by this point due to lower uterine segment development 1
    • Resolution is less likely with prior cesarean delivery 1
  2. 36-week TVS if placenta remains low-lying at 32 weeks 1

    • This scan informs mode of delivery discussion
    • Minimal placental migration occurs after 36 weeks 1
  3. Cervical length measurement at these scans provides additional risk stratification 1:

    • Cervical length <31 mm increases risk of emergency cesarean 16-fold (OR 16.4) 1
    • Cervical length <25 mm increases massive hemorrhage risk 7-fold (RR 7.2) 1

Management Based on Symptoms

Asymptomatic Women

Individualize care based on social circumstances including distance to hospital, transportation availability, and acceptance of blood products 1. Women managed at home must:

  • Have someone available to assist them
  • Ensure ready hospital access
  • Understand to present immediately for any bleeding (including spotting), contractions, or vague suprapubic discomfort 1

Women with Bleeding Episodes

Tailor hospitalization decisions to bleeding history, hemoglobin levels, and individual risk factors 1. For hospitalized patients, assess venous thromboembolism risk while balancing bleeding risk 1.

Antenatal Corticosteroids and Tocolysis

Administer corticosteroids at 34+0 to 35+6 weeks for all women with persistent low-lying placenta or previa 1. Give earlier if higher preterm birth risk exists 1.

Tocolysis may be considered for 48 hours to facilitate corticosteroid administration in symptomatic women, but never use tocolysis to prolong gestation if delivery is indicated for maternal or fetal concerns 1.

Delivery Planning

Timing of Delivery

For women with bleeding history or risk factors: Consider delivery at 34+0 to 36+6 weeks 1

For uncomplicated placenta previa: Deliver at 36+0 to 37+0 weeks 1

Mode of Delivery Decision

The internal os distance (IOD) at 36 weeks determines delivery approach 1:

IOD 11-20 mm:

  • Trial of labor is appropriate 1
  • Vaginal delivery success rate: 76.5-85% 2, 3
  • No increased severe postpartum hemorrhage risk compared to elective cesarean 4

IOD 1-10 mm:

  • Trial of labor possible but lower success (18.5-43% vaginal delivery) 4, 2, 3
  • Does not increase severe hemorrhage or maternal morbidity 4
  • Shared decision-making is essential 3

IOD >20 mm:

  • Manage as routine pregnancy
  • Vaginal delivery success: 82-94% 5, 3

Critical Delivery Preparations for Placenta Previa

All deliveries must occur in facilities with:

  • On-site blood transfusion services
  • Critical care access 1

Pre-delivery counseling must address:

  • Blood transfusion indications
  • Hysterectomy risk (higher with anterior placenta previa)
  • Document any refusal of blood products 1

Prevent and treat anemia throughout pregnancy as maternal hemoglobin <8.0 g/dL is the most common morbidity 1, 2.

Special Considerations

Prior cesarean delivery increases both placenta previa risk and placenta accreta spectrum risk—tailor follow-up timing to exclude accreta 1. Women with prior uterine surgery (cesarean or myomectomy with uterine penetration) have significantly higher posterior placenta accreta risk 6.

Common pitfall: Do not assume all low-lying placentas require cesarean delivery. The evidence strongly supports trial of labor when IOD is 11-20 mm, with outcomes comparable to elective cesarean and successful vaginal delivery in the majority of cases 4, 5, 3.

References

Guideline

placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a.

BJOG : an international journal of obstetrics and gynaecology, 2019

Research

Effect of a low-lying placenta on delivery outcome.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2009

Research

Vaginal delivery in women with a low-lying placenta: a systematic review and meta-analysis.

BJOG : an international journal of obstetrics and gynaecology, 2019

Research

Pregnancy and Delivery Outcomes in Women With Persistent Versus Resolved Low-Lying Placenta in the Late Third Trimester.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.